Thompson Clive and Partners
2
19M
1
0.50
1
- Areas of investment
Summary
Among the various public portfolio startups of the fund, we may underline TriVirix International Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Manufacturing, Medical Device.
The higher amount of exits for fund were in 2010. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2002.
The typical case for the fund is to invest in rounds with 9 participants. Despite the Thompson Clive and Partners, startups are often financed by The Aurora Funds, Enterprise Equity, Coastal Growth Partners. The meaningful sponsors for the fund in investment in the same round are The Aurora Funds, Frontier Growth, Tri-State Investment Group. In the next rounds fund is usually obtained by The Trelys Funds, The Aurora Funds, SunTrust Bank.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.50
- Investments by industry
- Medical (2)
- Manufacturing (2)
- Medical Device (2)
- Investments by region
-
- United States (2)
- Peak activity year
- 2002
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| TriVirix International | 30 Jul 2001 | Manufacturing, Medical Device, Medical | Late Stage Venture | 13M | United States, Minnesota |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.